Latest filing published 31 Jan 2023 for Meridian Bioscience INC.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Andrew S. Kitzmiller: trading record in brief
Andrew S. Kitzmiller (senior executive) discloses dealings in 2 companies, chiefly Hillenbrand, Inc. and Meridian Bioscience Inc. The record holds 10 filings, for trades running from 5 December 2020 to 31 January 2023.
Every open-market trade on record is a purchase: 1 purchase worth €90k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 5 share grants and 3 option exercises.
The record was last updated on 31 January 2023 with a transaction in Meridian Bioscience Inc. The last insider purchase was made public on 28 February 2022, 1,715 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Andrew S. Kitzmiller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,945 sharesCommon StockSEC:0001567619-23-001529:0
- 4,028 shares@ US$24.8675100.0% of flowCommon StockSEC:0001127602-22-006985:0Canonical exit: 26 May 2022 (T+90)
- 7,500 shares0Common StockSEC:0001127602-22-005952:0
- 884 sharesCommon StockSEC:0001214659-21-012818:0
4 of 4 declarations
